News and Events

Hatchtech completes financing round and commences Phase 3 program

13/12/2012 | Press Releases

Specialty pharmaceutical company Hatchtech Pty Ltd has completed a $6 million financing led by OneVentures Innovation Fund. This will enable the Company to commence the final stage of development of its novel head lice treatment product, DeOvo.

Download PDF